Tuesday, August 19, 2008 | Register | Login |   Search      
 

Clinical Pharmacology Services

AvivoClin’s custom, state-of-the-art clinical pharmacology research unit brings together an impressive blend of experience and services. AvivoClin’s management has performed a broad spectrum of clinical studies across virtually every therapeutic area. Working with local hospitals and organizations, we offer customized solutions for our clients’ early phase clinical research needs. As part of the Azopharma Product Development Group, we can also support all of your product development needs. From preclinical and bioanalytical services to formulation and CTM manufacturing, Azopharma is your product development partner.

Phase I Clinical Services – AvivoClin provides extensive Phase I Clinical Pharmacololgy services to support new drug applications and other product development goals.
Phase II-III Clinical Services – AvivoClin also provides services to support your later phase clinical activities including proof of concept and safety studies.
Bioanalytical Support –We provide the full spectrum of analytical techniques to support your clinical studies.
Regulatory Services – We can help you navigate the regulatory process and support you in your product development goals
Formulation Services – Through our parent company, Azopharma Product Development Group, we provide full formulation services for all major dosage forms in support of your clinical pharmacology studies.
CTM Manufacturing – Through the Azopharma Product Development Group we provide full CTM manufacturing services across all major dosage forms.
Preclinical Services – Comprehensive preclinical and toxicology services to support your strategic clinical pharmacology plan.
Phase I Express™- The Azopharma Product Development Group’s novel and proprietary approach to accelerating clinical trial material development.

 
Press Releases

July 24, 2008

Azopharma Announces the Addition of State of the Art Formulations Equipment

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented Xcelodose™ powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products.

Read More

 

Trade Shows

Contract Pharma:
New Brunswick, NJ
September 25-26

ICSE Frankfurt:
Frankfurt, Germany
Sept 30-Oct 2

BioPartnering Europe:
London, UK
October 12-14

ACCP
Louisville, KY
October 19-22

ISPE:
Boca Raton, FL
October 26-28

AAPS:
Atlanta, GA
November 17-20





Copyright 2007 AvivoClin Inc.   Terms Of Use   Privacy Statement   Site Map